{
    "title": "Merck buys rights to NewLink's Ebola vaccine",
    "url": "https://www.dailymail.co.uk/wires/afp/article-2847812/Merck-buys-rights-NewLinks-Ebola-vaccine.html",
    "date": "2014-11-24",
    "keywords": [
        "vaccine",
        "ebola",
        "health",
        "newlink",
        "agreement",
        "merck",
        "virus",
        "research",
        "government",
        "company",
        "institute",
        "component",
        "percent",
        "afp",
        "gmt",
        "november",
        "email",
        "drugmaker",
        "worldwide",
        "manufacture",
        "rvsvebov",
        "photo",
        "reception",
        "geneva",
        "university",
        "hospital",
        "batch",
        "rvsv",
        "microbiology",
        "laboratory",
        "missioneiro",
        "chad3",
        "glaxosmithkline",
        "allergy",
        "treatment",
        "outbreak",
        "west",
        "africa",
        "world",
        "year",
        "president",
        "step",
        "prevention",
        "control",
        "risk",
        "infection",
        "statementmerck",
        "expertise",
        "collaboration",
        "response",
        "institutes",
        "walter",
        "effort",
        "switzerland",
        "germany",
        "kenya",
        "effect",
        "beginning",
        "quarter",
        "drug",
        "companys",
        "iowa",
        "sale",
        "earlyafternoon",
        "trade"
    ],
    "category": [
        "wires",
        "afp"
    ]
}